Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,111) with videos related to
Page
of 112
Sort By:
Cell Host & Microbe
|
March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies
Samantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
May 2, 2024
Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: A national study
Faris G Bakri, Heyam H Mukattash, Hiam Esmeiran, et al.
Science Translational Medicine
|
July 17, 2015
HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition
Heather A Prentice, Georgia D Tomaras, Daniel E Geraghty, et al.
Journal of Virology
|
May 15, 2015
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research
Lindsay Wieczorek, Shelly J Krebs, Vaniambadi Kalyanaraman, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohorts
Philip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Journal of Virology
|
July 3, 2023
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
Jaime L Jensen, Rajeshwer S Sankhala, Vincent Dussupt, et al.
Nature Communications
|
May 29, 2025
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts
Philip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
The Journal of Infectious Diseases
|
May 29, 2012
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials
David C Montefiori, Chitraporn Karnasuta, Ying Huang, et al.
Journal of Virology
|
November 24, 2012
Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion
S Munir Alam, Hua-Xin Liao, Georgia D Tomaras, et al.
The Journal of Clinical Investigation
|
March 18, 2020
Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound
Evan M Cale, Hongjun Bai, Meera Bose, et al.
Page
of 112
Search research articles
Search
Showing results (1041-1050 of 1,111) with videos related to
Sort By:
Page
of 112
Cell Host & Microbe
|
March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies
Samantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
May 2, 2024
Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: A national study
Faris G Bakri, Heyam H Mukattash, Hiam Esmeiran, et al.
Science Translational Medicine
|
July 17, 2015
HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition
Heather A Prentice, Georgia D Tomaras, Daniel E Geraghty, et al.
Journal of Virology
|
May 15, 2015
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research
Lindsay Wieczorek, Shelly J Krebs, Vaniambadi Kalyanaraman, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohorts
Philip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Journal of Virology
|
July 3, 2023
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
Jaime L Jensen, Rajeshwer S Sankhala, Vincent Dussupt, et al.
Nature Communications
|
May 29, 2025
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts
Philip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
The Journal of Infectious Diseases
|
May 29, 2012
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials
David C Montefiori, Chitraporn Karnasuta, Ying Huang, et al.
Journal of Virology
|
November 24, 2012
Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion
S Munir Alam, Hua-Xin Liao, Georgia D Tomaras, et al.
The Journal of Clinical Investigation
|
March 18, 2020
Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound
Evan M Cale, Hongjun Bai, Meera Bose, et al.
Page
of 112